[144] Cellebrite DI Ltd. Warrants SEC Filing

Rhea-AI Filing Summary

Form 144 notice for CLBTW (Cellebrite DI Ltd.) shows a proposed public sale of 10,281 common shares through Morgan Stanley Smith Barney (NASDAQ) with an aggregate market value of $164,651.09 and an approximate sale date of 08/26/2025. The filer reports acquiring 4,984 shares by stock option exercise on 08/26/2025 (paid in cash) and restricted stock grants of 3,387 shares on 08/14/2025 and 1,910 shares on 08/14/2024. The filing also discloses a prior sale on 08/25/2025 of 37,965 shares for gross proceeds of $608,243.82 by Zohar Tadmor. The notice includes the signers representation that no undisclosed material adverse information is known.

Positive

• Compliance: The filer provided detailed Rule 144 information including acquisition dates, transaction types, and payment method for the option exercise.
• Transparency: The filing discloses both the proposed sale and a recent sale with exact share counts and gross proceeds.

Negative

• Context missing: The filing does not state beneficial ownership percentages or outstanding float, so material impact to shareholders cannot be determined.
• No trading plan disclosed: The document does not indicate a Rule 10b5-1 trading plan adoption date, leaving timing context unclear.

Insights

Securities Analyst

TL;DR: Insider-originated sales disclosed; transaction sizes are modest relative to many issuers.

The filing documents an intended sale of 10,281 common shares via Morgan Stanley with a stated market value of $164,651.09 and notes recent acquisitions through option exercise and restricted stock grants. It also reports a discrete prior sale of 37,965 shares generating $608,243.82. From a market-impact perspective these are specific insider transactions required to be reported under Rule 144. The filing itself does not provide company financials, outstanding float percentage, or context on ownership concentration, so materiality to shareholders cannot be fully assessed from this notice alone.

Corporate Governance Specialist

TL;DR: Required compliance disclosure of resale; no statements of undisclosed material adverse facts were made.

The document fulfills Rule 144 disclosure obligations by listing the securities to be sold, acquisition dates, acquisition types (option exercise, restricted stock), and payment method for the option exercise. It includes the mandatory representation that the filer is unaware of undisclosed material adverse information. The filing lacks governance context such as whether a trading plan (Rule 10b5-1) exists, and provides no details on beneficial ownership percentages, limiting conclusions about insider intent or governance implications.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	10281	164651.09	244469106	08/26/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/26/2025	Stock Option Exercise	ISSUER			4984	08/26/2025	Cash
Common	08/14/2025	Restricted Stock	ISSUER			3387	08/14/2025	Not Applicable
Common	08/14/2024	Restricted Stock	ISSUER			1910	08/14/2024	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
ZOHAR TADMOR 94 Shlomo Shmelzer Road Petah Tikva L3 4970602	Common	08/25/2025	37965	608243.82

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What shares does the Form 144 for CLBTW propose to sell?

The notice proposes sale of 10,281 common shares via Morgan Stanley Smith Barney with an aggregate market value of $164,651.09 and an approximate sale date of 08/26/2025.

What recent acquisitions funded the shares to be sold?

The filing shows acquisitions of 4,984 shares by stock option exercise on 08/26/2025 (paid in cash), 3,387 restricted shares on 08/14/2025, and 1,910 restricted shares on 08/14/2024.

Were there prior sales disclosed in the past three months?

Yes. A sale on 08/25/2025 by Zohar Tadmor of 37,965 shares generated gross proceeds of $608,243.82.

Which broker is handling the proposed sale?

The broker listed is Morgan Stanley Smith Barney LLC Executive Financial Services located at 1 New York Plaza, New York, NY; the filing lists the exchange as NASDAQ.

Does the filing state the filer knows of any undisclosed material adverse information?

The signer represents that they do not know any material adverse information regarding the issuer that has not been publicly disclosed.